Deng Cheng sold $45K of ZEPP
Deng Cheng (Chief Financial Officer) sold 9,836 shares of Zepp Health Corp (ZEPP) at $4.61 on 2026-06-26.
How this was made
The 30-second read
Why it matters
The newest fact is the CFO’s disclosed sale details (shares, price, total value, and post-transaction holdings).
Market read
Insider selling can influence near-term sentiment, but the article provides no operational or guidance change.
What to watch
No 10b5-1 plan is mentioned; traders may still treat the absence of a stated plan as marginally more informative, but the transaction size is modest.
Background
This is an SEC Form 4 insider transaction disclosure for Zepp Health Corp.
Ticker impact
CFO Deng Cheng filed a Form 4 open-market sale of 9,836 shares at $4.61 on 2026-06-26, totaling $45,343.96.
Low likelihood of a sustained price move; any reaction is likely short-lived unless accompanied by other disclosures.
The filing is a standard Form 4 open-market sale with no 10b5-1 plan stated and no accompanying operational/regulatory news in the text.
Market effects
Minimal; insider-sale disclosures typically do not reset sector expectations without additional company-specific catalysts.
None indicated.
None indicated.
Counterpoint
The sale could be unrelated to company outlook (tax/portfolio rebalancing), especially given it’s an open-market transaction.
Key entities
- issuerZepp Health Corp
Subject of the Form 4 insider transaction disclosure.
- insiderDeng Cheng
Chief Financial Officer who reported the open-market sale.
